IMMUNE CHECKPOINT INHIBITORS
Clinical trials for IMMUNE CHECKPOINT INHIBITORS explained in plain language.
Never miss a new study
Get alerted when new IMMUNE CHECKPOINT INHIBITORS trials appear
Sign up with your email to follow new studies for IMMUNE CHECKPOINT INHIBITORS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New triple therapy targets Hard-to-Treat bile duct cancer
Disease control Not yet recruitingThis study tests a combination of three drugs (disitamab vedotin, lenvatinib, and a PD-1 inhibitor) in 65 adults with advanced HER2-positive bile duct cancer that cannot be removed by surgery. The goal is to see if the combo shrinks tumors and controls the disease. Participants w…
Matched conditions: IMMUNE CHECKPOINT INHIBITORS
Phase: PHASE2 • Sponsor: Peking Union Medical College Hospital • Aim: Disease control
Last updated May 26, 2026 04:41 UTC
-
New combo therapy may spare breast cancer patients from Heart-Harming drugs
Disease control Not yet recruitingThis study tests a new approach for people with early-stage triple-negative breast cancer. It combines an immunotherapy drug (QL1706) with chemotherapy before surgery. The key idea is to use scans and biopsies after the first part of treatment to see who responds well. Those who …
Matched conditions: IMMUNE CHECKPOINT INHIBITORS
Phase: PHASE2 • Sponsor: Tianjin Medical University Cancer Institute and Hospital • Aim: Disease control
Last updated May 26, 2026 04:31 UTC
-
Waking up the immune system: could a cancer drug help HIV patients beat stubborn infections?
Disease control Not yet recruitingThis study tests a drug called Sintilimab, which is normally used for cancer, to see if it can help people with HIV who have infections that won't go away with standard treatments. The drug works by waking up tired immune cells. About 50 adults will receive the drug alongside the…
Matched conditions: IMMUNE CHECKPOINT INHIBITORS
Phase: PHASE1, PHASE2 • Sponsor: Shanghai Public Health Clinical Center • Aim: Disease control
Last updated May 22, 2026 13:51 UTC